Cooperative Program for Modeling Clinical Transplantation

The Cooperative Program for Modeling Clinical Transplantation is a forecasted federal funding opportunity administered by the National Institutes of Health within the U.S. Department of Health and Human Services, specifically through the National Institute of Allergy and Infectious Diseases. This program aligns with the institute’s mission to advance research on immune-mediated diseases and improve outcomes in transplantation science. It is designed as a cooperative agreement, indicating substantial involvement from the funding agency in programmatic direction and oversight. The initiative is authorized under the Public Health Service Act and corresponding federal regulations, supporting biomedical research that contributes to public health advancements. The primary objective of this program is to support the development of innovative, clinically relevant models that can better simulate immune responses in human solid organ transplantation. The funding opportunity emphasizes the need for both in vitro and in vivo systems that can accurately replicate local and systemic immune mechanisms. The program encourages the use of new approach methods and refined animal models, particularly those that address current limitations in translational research and reduce reliance on nonhuman primates. Proposed models must demonstrate relevance to clinical outcomes and be capable of overcoming known barriers that have historically hindered the translation of therapies from research to clinical application. Allowable activities under this program include the development and validation of experimental systems such as immune-competent microphysiological systems, organoids, ex vivo perfused human organs, precision-cut tissue slices, and computational systems biology models. Applicants are expected to design projects that contribute to the advancement of therapeutic strategies in transplantation by improving predictive accuracy and biological relevance. The program also places a strong emphasis on data sharing, reproducibility, and the establishment of standards and best practices across the research community. While specific budget constraints per award are not detailed, the total program funding is estimated at 1,280,000 dollars with an anticipated three awards. Eligibility for this opportunity is broad and inclusive, encompassing a wide range of organizational types. Eligible applicants include public and private institutions of higher education, nonprofit organizations with or without 501(c)(3) status, for-profit entities including small businesses, and various levels of government including state, county, city, and tribal governments. Additional eligible entities include public housing authorities, independent school districts, and regional or community-based organizations. Federal agencies and U.S. territories are also permitted to apply, reflecting the program’s intent to foster diverse collaboration across sectors. The application process is expected to follow standard NIH submission procedures, likely requiring registration in federal systems such as Grants.gov and adherence to NIH application guidelines. While specific application components are not detailed in the forecast, applicants can expect to prepare comprehensive research proposals, including scientific plans, budgets, and supporting documentation. There is no cost-sharing or matching requirement associated with this funding opportunity, which may lower barriers to entry for eligible applicants. The timeline for this forecasted opportunity indicates an estimated posting date of July 10, 2026, with applications due by October 9, 2026. Awards are anticipated to be issued by July 1, 2027, with project start dates aligned to the same timeframe. As a forecasted opportunity, it is currently in an early engagement stage, allowing prospective applicants time to prepare. Interested parties are encouraged to monitor updates and direct inquiries to the program contact via the provided email address. This opportunity does not explicitly state recurrence, suggesting it may be a one-time or irregular funding cycle.